Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Channing Laboratory, Brigham and Women's Hospital, Boston, MA 02115, USA. wendy.chen@channing.harvard.edu
It is increasingly being recognized that breast cancer does not represent a single homogeneous disease; instead, the hormone-receptor status defines important clinical and etiologic differences. We review the epidemiologic data on differences in risk-factor associations by hormone-receptor status and highlight major trends in the literature. We discuss the development and evaluation of breast cancer risk models, with a focus on the Rosner and Colditz model, which can separately estimate the risk of hormone-receptor-positive and hormone-receptor-negative breast cancers. We also discuss the clinical implications of accounting for hormone-receptor status in breast cancer risk-prediction models.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on